Home/Filings/5/0001264931-15-000087
5//SEC Filing

Immune Therapeutics, Inc. 5

Accession 0001264931-15-000087

CIK 0001559356operating

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 12:28 PM ET

Size

5.3 KB

Accession

0001264931-15-000087

Insider Transaction Report

Form 5
Period: 2014-12-31
Griffin Noreen
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Award

    COMMON STOCK

    2014-06-16+02,685,000 total(indirect: By Trust)
Footnotes (1)
  • [F1]The total number of shares has been adjusted to reflect shares inadvertently not included in previous reports. These shares are held in an irrevocable trust for the benefit of the reporting person's children and grandchildren. The reporting person's sister-in-law is trustee of the trust.

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeoperating
IncorporatedFL

Related Parties

1
  • filerCIK 0001559356

Filing Metadata

Form type
5
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 12:28 PM ET
Size
5.3 KB